JP-2022539728-A5 -

Dates

Publication Date

20230522

Application Date

20200625

Description

The DS composition according to the present invention, which contains black humic material and β-glucan, is formulated for use in regulating anaerobic microbial ecosystems. (Note) The technical concepts that can be understood from the embodiments and modifications described herein are described below. [Item 1] A deconstructed soil composition containing black humic material and β-glucan. [Item 2] The composition according to item 1, wherein the β-glucan is resistant to microbial degradation. [Item 3] The composition according to items 1 and 2, wherein the β-glucan is a fungal type β-1,3/1,6-glucan. [Item 4] The composition according to item 3, wherein the β-glucan is β-1,3/1,6-glucan obtained from yeast. [Item 5] The composition according to items 1 to 4, wherein the black humic material comprises iron and lignocellulose. [Item 6] The composition according to any one of items 1 to 5, wherein the black humic material is of the leonardite type. [Item 7] A composition containing clay minerals, as described in any one of items 1 to 6. [Item 8] The composition according to any one of items 1 to 7, wherein the ratio of β-1,3/1,6-glucan to black humic material is in the range of 1:100 to 1:1, preferably 5:100. [Item 9] The composition according to item 8, wherein the ratio of β-1,3/1,6-glucan to black humic material is 3.5:100. [Item 10] A composition according to any one of items 1 to 8, wherein the ratio of β-1,3/1,6-glucan to black humic material to clay mineral is in the range of 1:100:5 to 5:100:15. [Item 11] The composition according to item 10, wherein the ratio of β-1,3/1,6-glucan to black humic material to clay mineral is 3.5:100:10. [Item 12] A composition according to any one of items 1 to 11, for use in the regulation of anaerobic microbial ecosystems. [Item 13] Use of any one of the compositions described in item 1 to 12 in the treatment of dysbiosis in a target organism, wherein the target organism is selected from the group consisting of mammals, birds, and aquaculture species. [Item 14] The use described in item 13, wherein the aforementioned mammal is a human. [Item 15] The use described in item 13, wherein the mammal is a pet or livestock. [Item 16] Use as described in item 13, in which oxygen-sensitive beneficial intestinal bacteria are selectively favored under anaerobic and microaerophilic conditions. [Item 17] Use as described in item 13, which selectively disadvantages oxygen-sensitive harmful enterobacteria under anaerobic and microaerophilic conditions. [Item 18] Use as described in item 13 to promote the growth of Faecalibacterium prausnitzii under anaerobic conditions. [Item 19] The growth of Prevotella copri is enhanced under anaerobic conditions, as described in item 13. [Item 20] The use described in item 13 promotes the proliferation of Ackermansia muciniphylla under anaerobic conditions. [Item 21] The growth of Metanobrevibacter smithii is enhanced under anaerobic conditions, as described in item 13. [Item 22] The growth of Bifidobacterium species is enhanced under anaerobic conditions, as described in item 13. [Item 23] The use described in item 13 promotes the growth of Lactobacillus species under anaerobic conditions. [Item 24] The proliferation of Faecalibacterium prausnitzii is enhanced under microaerophilic conditions, as described in item 13. [Item 25] Under microaerophilic conditions, the proliferation of Prevotella copri is enhanced, as described in item 13. [Item 26] Under microaerophilic conditions, the proliferation of Ackermansia muciniphylla is enhanced, as described in item 13. [Item 27] Under microaerophilic conditions, the proliferation of Metanobrevibacter smithii is enhanced, as described in item 13. [Item 28] Under microaerophilic conditions, the proliferation of Bifidobacterium species is enhanced; use as described in item 13. [Item 29] The use described in item 13 promotes the growth of Lactobacillus species under microaerophilic conditions. [Item 30] Use as described in item 13, when anaerobic conditions make it difficult for Clostridium perflingens to grow. [Item 31] Use as described in item 13, which makes the growth of Finegordia magna unfavorable under anaerobic conditions. [Item 32] Use as described in item 13, which makes propagation of Aristipes shahii unfavorable under anaerobic conditions. [Item 33] Use as described in item 13, which makes the propagation of Staphylococcus species unfavorable under anaerobic conditions. [Item 34] The use described in item 13 makes it difficult for Bacteroides umiformis to grow under anaerobic conditions. [Item 35] Use as described in item 13, which makes the propagation of Bacteroides vulgatus unfavorable under anaerobic conditions. [Item 36] Use as described in item 13, when microaerophilic conditions make it difficult for Clostridium perflingens to grow. [Item 37] Use as described in item 13, which makes the propagation of Finegordia magna unfavorable under microaerophilic conditions. [Item 38] Under microaerophilic